128 related articles for article (PubMed ID: 38584352)
1. Hypoperfusion in Alzheimer's Disease-Prone Regions and Dementia Conversion in Parkinson's Disease.
Chun MY; Lee T; Kim SH; Lee HS; Kim YJ; Lee PH; Sohn YH; Jeong Y; Chung SJ
Clin Nucl Med; 2024 Jun; 49(6):521-528. PubMed ID: 38584352
[TBL] [Abstract][Full Text] [Related]
2. Differential Implications of Cerebral Hypoperfusion and Hyperperfusion in Parkinson's Disease.
Jeong SH; Kim SH; Park CW; Lee HS; Lee PH; Kim YJ; Sohn YH; Jeong Y; Chung SJ
Mov Disord; 2023 Oct; 38(10):1881-1890. PubMed ID: 37489576
[TBL] [Abstract][Full Text] [Related]
3. Is the cingulate island sign a marker for early dementia conversion in Parkinson's disease?
Chung SJ; Kim SH; Park CW; Lee HS; Kim YJ; Lee PH; Jeong Y; Sohn YH
Eur J Neurol; 2023 Dec; 30(12):3732-3740. PubMed ID: 37505994
[TBL] [Abstract][Full Text] [Related]
4. Patterns of regional cerebral hypoperfusion in early Parkinson's disease: Clinical implications.
Chung SJ; Kim SH; Park CW; Lee HS; Yun M; Kim YJ; Sohn YH; Jeong Y; Lee PH
Parkinsonism Relat Disord; 2024 Apr; 121():106024. PubMed ID: 38377658
[TBL] [Abstract][Full Text] [Related]
5. Hippocampal Perfusion Affects Motor and Cognitive Functions in Parkinson Disease: An Early Phase
Chun MY; Chung SJ; Kim SH; Park CW; Jeong SH; Lee HS; Lee PH; Sohn YH; Jeong Y; Kim YJ
Ann Neurol; 2024 Feb; 95(2):388-399. PubMed ID: 37962393
[TBL] [Abstract][Full Text] [Related]
6. Dual-phase
Kim MS; Park DG; An YS; Yoon JH
Eur J Neurol; 2023 Feb; 30(2):344-352. PubMed ID: 36288409
[TBL] [Abstract][Full Text] [Related]
7. Correlating Parkinson's disease motor symptoms with three-dimensional [(18)F]FP-CIT PET.
Chung M; Park YS; Kim JS; Kim YJ; Ma HI; Jang SJ; Huh R; Kim HS; Kim WC
Jpn J Radiol; 2015 Oct; 33(10):609-18. PubMed ID: 25952404
[TBL] [Abstract][Full Text] [Related]
8. Cholinesterase inhibitor use does not significantly influence the ability of 123I-FP-CIT imaging to distinguish Alzheimer's disease from dementia with Lewy bodies.
Taylor JP; Colloby SJ; McKeith IG; Burn DJ; Williams D; Patterson J; O'Brien JT
J Neurol Neurosurg Psychiatry; 2007 Oct; 78(10):1069-71. PubMed ID: 17299017
[TBL] [Abstract][Full Text] [Related]
9. Early diagnosis of Alzheimer's disease and Parkinson's disease associated with dementia using cerebral perfusion SPECT.
Song IU; Chung YA; Chung SW; Jeong J
Dement Geriatr Cogn Disord; 2014; 37(5-6):276-85. PubMed ID: 24356537
[TBL] [Abstract][Full Text] [Related]
10. Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An
Joling M; Vriend C; Raijmakers PGHM; van der Zande JJ; Lemstra AW; Berendse HW; Booij J; van den Heuvel OA
Neuroimage Clin; 2019; 22():101755. PubMed ID: 30884365
[TBL] [Abstract][Full Text] [Related]
11. Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using 123I-FP-CIT SPECT.
Colloby SJ; Williams ED; Burn DJ; Lloyd JJ; McKeith IG; O'Brien JT
Eur J Nucl Med Mol Imaging; 2005 Oct; 32(10):1176-85. PubMed ID: 15931516
[TBL] [Abstract][Full Text] [Related]
12. Frontal atrophy as a marker for dementia conversion in Parkinson's disease with mild cognitive impairment.
Chung SJ; Yoo HS; Lee YH; Lee HS; Ye BS; Sohn YH; Kwon H; Lee PH
Hum Brain Mapp; 2019 Sep; 40(13):3784-3794. PubMed ID: 31090134
[TBL] [Abstract][Full Text] [Related]
13. Regional cerebral blood flow in Parkinson's disease with and without dementia.
Firbank MJ; Colloby SJ; Burn DJ; McKeith IG; O'Brien JT
Neuroimage; 2003 Oct; 20(2):1309-19. PubMed ID: 14568499
[TBL] [Abstract][Full Text] [Related]
14. Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease.
Mito Y; Yoshida K; Yabe I; Makino K; Hirotani M; Tashiro K; Kikuchi S; Sasaki H
Clin Neurol Neurosurg; 2005 Aug; 107(5):396-403. PubMed ID: 16023534
[TBL] [Abstract][Full Text] [Related]
15. Clinical Correlates of Cerebral Amyloid Deposition in Parkinson's Disease Dementia: Evidence from a PET Study.
Palermo G; Tommasini L; Aghakhanyan G; Frosini D; Giuntini M; Tognoni G; Bonuccelli U; Volterrani D; Ceravolo R
J Alzheimers Dis; 2019; 70(2):597-609. PubMed ID: 31256138
[TBL] [Abstract][Full Text] [Related]
16. Comparing cerebral perfusion in Alzheimer's disease and Parkinson's disease dementia: an ASL-MRI study.
Le Heron CJ; Wright SL; Melzer TR; Myall DJ; MacAskill MR; Livingston L; Keenan RJ; Watts R; Dalrymple-Alford JC; Anderson TJ
J Cereb Blood Flow Metab; 2014 Jun; 34(6):964-70. PubMed ID: 24619276
[TBL] [Abstract][Full Text] [Related]
17. Association Between White Matter Connectivity and Early Dementia in Patients With Parkinson Disease.
Chung SJ; Kim YJ; Jung JH; Lee HS; Ye BS; Sohn YH; Jeong Y; Lee PH
Neurology; 2022 May; 98(18):e1846-e1856. PubMed ID: 35190467
[TBL] [Abstract][Full Text] [Related]
18. The value of multimodal imaging with
Miyagawa T; Przybelski SA; Maltais D; Min HK; Jordan L; Lesnick TG; Chen Q; Graff-Radford J; Jones D; Savica R; Knopman D; Petersen R; Kremers WK; Forsberg LK; Fields JA; Ferman TJ; Allen L; Parisi J; Reichard RR; Murray M; Dickson D; Boeve BF; Kantarci K; Lowe VJ
Neurobiol Aging; 2021 Mar; 99():11-18. PubMed ID: 33422890
[TBL] [Abstract][Full Text] [Related]
19. Confirmation of
Maltais DD; Jordan LG; Min HK; Miyagawa T; Przybelski SA; Lesnick TG; Reichard RR; Dickson DW; Murray ME; Kantarci K; Boeve BF; Lowe VJ
J Nucl Med; 2020 Nov; 61(11):1628-1635. PubMed ID: 32198310
[TBL] [Abstract][Full Text] [Related]
20. Spatiotemporal Progression Patterns of Dopamine Availability and Deep Gray Matter Volume in Parkinson Disease-Related Cognitive Impairment.
Oh Y; Kim JS; Lyoo CH; Park G; Kim H
Neurology; 2024 Jul; 103(2):e209498. PubMed ID: 38885485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
